Related Experiment Video
Updated: May 26, 2026

07:08
The Lambda Select cII Mutation Detection System
Published on: April 26, 2018
Bacterial mutagenicity assays: test methods
1Old Barn, Cherry Orchard Lane Wyddial, Hertfordshire, SG9 0EN, UK. dgg130679@yahoo.co.uk
Methods in Molecular Biology (Clifton, N.J.)
|December 8, 2011
Summary
The bacterial reverse mutation assay, using Salmonella typhimurium and E. coli strains, detects chemical mutagens by identifying gene mutations. This widely used test screens new chemicals and drugs for their mutagenic potential.
Area of Science:
- Microbiology
- Genetics
- Toxicology
Background:
- Bacterial reverse mutation assays are standard for detecting chemically induced gene mutations.
- The plate incorporation assay uses Salmonella typhimurium and E. coli strains to identify mutagens.
Purpose of the Study:
- To detail procedures for the bacterial reverse mutation assay.
- To provide guidance on assay variations and troubleshooting.
Main Methods:
- Utilizes auxotrophic bacterial strains (S. typhimurium and E. coli) with specific mutations.
- Detects mutations by observing bacterial growth on minimal media, indicating reversion to amino acid independence.
- Incorporates a metabolic activation system (S9-mix) to assess mutagenicity of compounds requiring metabolic activation.
Main Results:
- Mutagenic potential is indicated by an increased number of revertant colonies in the presence of a chemical mutagen.
- The increase in revertant colonies is typically dose-related.
- The assay is sensitive to various DNA-damaging mechanisms due to different bacterial strains used.
Conclusions:
- The bacterial reverse mutation assay is a crucial initial screen for mutagenic potential of chemicals and drugs.
- Detailed procedures and troubleshooting are essential for reliable results.
- The assay's versatility allows for detection of a wide range of mutagens.
Related Concept Videos
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Methods to Assess Microbial Populations
Assessing microbial populations is crucial for understanding microbial roles in health, ecology, and industry. Various complementary techniques—both culture-based and molecular—enable detailed analysis of microbial abundance, diversity, and function.Viable Plate CountThe viable plate count is a traditional culture-based method used to estimate the number of living microbes in a sample. After serial dilution, the sample is spread onto nutrient agar plates. Each viable cell forms a visible...
In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Spontaneous and Induced Mutations
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
